SMT Secures Italian Contract for Advanced Hydra TAVI Devices

Sahajanand Medical Technologies Ltd. (SMT) will supply its Hydra Transcatheter Aortic Valve Implantation (TAVI) devices to Italian hospitals under a new CONSIP 2-year tender. The innovative Hydra TAVI devices aim to improve patient outcomes in treating aortic stenosis. Key SMT figures highlight the significance of this milestone.

Sahajanand Medical Technologies Ltd. (SMT) has secured a pivotal 2-year tender from Italy's national CONSIP, allowing it to supply its cutting-edge Hydra Transcatheter Aortic Valve Implantation (TAVI) devices to hospitals across Italy.

This tender marks a significant milestone for SMT, enhancing patient care by providing advanced solutions for treating aortic stenosis. The Hydra TAVI device, known for its optimal radial strength and supra-annular valve positioning, is now accessible for procurement by all National Health Service (NHS) hospitals in Italy.

Gaurav Goel, Global Head of the Structural Heart Division at SMT, expressed pride in being recognized by the CONSIP tender, which validates the quality and effectiveness of Hydra TAVI technology. Gennaro Broya de Lucia, Distributor Manager Europe, emphasized the collaborative effort behind this achievement, particularly praising national importer Eukon. This value-based procurement aligns with SMT's commitment to high-quality and cost-efficient healthcare, solidifying its position as a leader in medical technology.

(With inputs from agencies.)